Teva Branded Pharmaceutical Products R&d Llc

This study tests an experimental drug called TEV-53408 in 50 adults with celiac disease who already follow a gluten-free diet. Participants will be exposed to small amounts of gluten to see if the drug can reduce intestinal damage and symptoms. The goal is to find a safe way to m…

This study was designed to test the safety and best dose of a new drug, TAK-573, when used with standard treatments for people with multiple myeloma that had returned or stopped responding to therapy. It was planned for about 0 participants who had already tried at least two prio…

This study tests two different maintenance doses of the drug TEV-48574 given as a shot every 4 weeks in adults with moderate to severe ulcerative colitis or Crohn's disease. Participants must have completed a previous 14-week study of the same drug. The goal is to see if the drug…

This early-stage trial tests a new drug called TEV-53408 in 38 adults with vitiligo, a condition that causes white patches on the skin. The main goal is to see if the drug is safe. Participants receive injections for 24 weeks and are followed for over a year. This study does not …